Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.
This triple-blind Randomized Controlled Trial (RCT) aims to investigate the effectiveness of autologous PRP intra ovarian infusion on reactivating ovarian functionality and on promoting folliculogenesis in regard to menopausal women. PRP is blood plasma prepared from fresh whole blood that has been enriched with platelets. It is collected from peripheral veins and contains several growth factors such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), transforming growth factor (TGF) and other cytokines all of which stimulate tissue proliferation and growth. PRP has been employed in several medical conditions in Orthopedics, Dermatology, and Ophthalmology for wound healing. It's efficacy in ovarian rejuvenation and reactivation and endometrial regeneration has not been fully elucidated. This study aims to investigate the effect of autologous PRP intra ovarian infusion on restoring ovarian tissue functionality in menopausal women.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
100
Autologous PRP intra ovarian infusion
Autologous PFP intra ovarian infusion
Genesis AC
Athens, Greece
RECRUITINGRestoration of menstrual cycle
Menstrual cycle restoration
Time frame: Three months
Serum FSH levels
Serum FSH levels evaluated monthly for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
Serum AMH levels
Serum AMH levels evaluated monthly for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
Serum estradiol levels
Serum estradiol levels evaluated monthly for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
Serum LH levels
Serum LH levels evaluated monthly for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
Serum progesterone levels
Serum progesterone levels evaluated monthly for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
Antral Follicle Count
AFC evaluated monthly, on day 2 of the menstrual cycle, for three consecutive months.
Time frame: Follow-up period of three months entailing monthly evaluation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.